Coca-Cola Europacific Partners (NASDAQ:CCEP)
| Market Cap | 49.13B+21.1% |
| Revenue (ttm) | 21.35B+13.6% |
| Net Income | 2.00B+6.7% |
| EPS | 4.44+7.9% |
| Shares Out | 443.22M |
| PE Ratio | 22.28 |
| Forward PE | 23.10 |
| Dividend | $2.03(2.05%) |
| Ex-Dividend Date | May 15, 2026 |
| Volume | 1,597,370 |
| Open | 113.76 |
| Previous Close | 114.23 |
| Day's Range | 110.80 - 114.17 |
| 52-Week Range | 84.66 - 114.55 |
| Beta | 0.48 |
| Analysts | Buy |
| Price Target | 110.00(-0.76%) |
| Earnings Date | Feb 18, 2027 |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About CCEP
Coca-Cola Europacific Partners PLC (CCEP), along with its affiliated entities, focuses on the creation, distribution, and sale of a wide array of non-alcoholic, ready-to-consume beverages. Their diverse product portfolio includes sparkling drinks, still and enhanced water products, isotonic options, teas, coffees, juices, as well as a variety of energy drinks and mixers. These offerings are marketed under numerous prominent brands, notably flagship names such as Coca-Cola, Fanta, Sprite, and Monster Energy, among a host of others. In addition to its primary beverage business, CCEP also oversees bottling operations and other related activities. As of March 15, 2022, the company served an estimated 600 million consumers. Founded in 1986, the firm maintains its headquarters in Uxbridge, United Kingdom. It officially rebranded as Coca-Cola Europacific Partners PLC in May 2021, having previously operated under the name Coca-Cola European Partners plc.
$CCEP stock is featured in our Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of CCEP by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Alan ArmstrongSenate / R | Purchase$1.00K – $15.00K | Mar 30, 2026 |
Recently reported changes in CCEP holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CCEP's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CCEP Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New CCEP patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CCEP from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in CCEP
| ETF | Est. Holding Size |
|---|---|
| QQQInvesco QQQ Trust, Series 1 | $1.01B |
| QQQMInvesco NASDAQ 100 ETF | $227.38M |
| IEFAiShares Core MSCI EAFE ETF | $175.39M |
| EFAiShares MSCI EAFE ETF | $79.76M |
| FVLFirst Trust Value Line 100 Exchange-Traded Fund | $35.34M |
| FVDFirst Trust Value Line Dividend Index Fund | $35.34M |
Estimated from each fund’s disclosed top holdings × AUM
CCEP Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from CCEP’s recent data — informational, not investment advice
Recent Insider Activity
No Form 4 filings in the last 90 days.